Bioblast Pharma Ltd. (ORPN) slipped -8.94% or -0.16 to $1.63. It is about 38025 shares traded, which is 55.93% compare to the average total volume 67988. The market cap of ORPN is $5.45 million. The year to date change is -28.31%. The 52 week price range is from $1.49 to $5.99. Price of ORPN have changed 4.07% during last week. It have changed -21.15% over last month, -14.35% over last 3 months, -28.97% over last 6 months and -33.13% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ORPN is 2.09. It is 28.22% above current price. The 200-day Moving Averages for ORPN is 2.32. It is 42.33% above current price. The 52-week High is 5.99. It is 267.48% from the current price. The 52-week Low is 1.49. It is -8.59% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of ORPN is 0.33 on 2018-06-15. Short % to float is 3.32%. There are some statistics of ORPN. It is has market cap $5.45 million. The share outstanding is 3.34 million. The average volume is 67988. The percent of top 15 Institution holding is 6.90%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ORPN is -100.24%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ORPN is -83.43%.